Evidence map›Paper›PMID 28434169›Full record

ReviewCurrent HIV/AIDS reports2017

Inflammation, Immune Activation, and Antiretroviral Therapy in HIV.

Corrilynn O Hileman, Nicholas T Funderburg

Abstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 166 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
166citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

166 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Trial
  12. Trial
  13. Trial
  14. Article
  15. Skin Carotenoid Scores Reflect Immune Status among Children Living with HIV in Tanzania.The American journal of tropical medicine and hygiene · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

106 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Corrilynn O HilemanCase Western Reserve University School of Medicine, 10900 Euclid Ave, Cleveland, OH, 44106, USA. corrilynn.hileman@case.edu.
Nicholas T FunderburgSchool of Health and Rehabilitation Sciences, Division of Medical Laboratory Science, Ohio State University, 535A Atwell Hall, 453 W. 10th Ave, Columbus, OH, 43210, USA.

Funding

Cellular mediators of vascular inflammation in treated HIV-infectionR01HL134544 · NHLBI · OHIO STATE UNIVERSITY · PI FUNDERBURG, NICHOLAS T. · 2016 to 2019
$3.2M
Vitamin D Status, Inflammation and Cardiac Risk in HIVK23HL116209 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI HILEMAN, CORRILYNN OLESKY · 2013 to 2017
$734k
NHLBI NIH HHS K23 HL116209NHLBI NIH HHS R01 HL134544
6 · The paper itself

Abstract

purpose of reviewThis review focuses on the differential effects of contemporary antiretrovirals on systemic inflammation as heightened immune activation is linked to important co-morbidities and mortality with HIV infection. RECENT

findingsAntiretroviral therapy (ART) reduces dramatically systemic inflammation and immune activation, but not to levels synchronous with HIV-uninfected populations. In one ART initiation trial, integrase inhibitors appear to reduce inflammation to a greater degree than non-nucleoside reverse transcriptase inhibitors (NNRTIs); however, it is not clear that there are beneficial effects on inflammation resulting from treatment with integrase inhibitors compared to PIs, between PIs and NNRTIs, between specific nucleoside reverse transcriptase inhibitors, or with maraviroc in ART-naïve patients. In ART switch studies, changing to an integrase inhibitor from a PI-, NNRTI-, or enfuvirtide-containing regimen has resulted in improvement in several markers of inflammation. Additional research is needed to conclusively state whether there are clear differences in effects of specific antiretrovirals on inflammation and immune activation in HIV.

Indexed as

Antiretroviral Therapy, Highly ActiveInflammationAnti-HIV AgentsHIV-1HIV InfectionsHumansReverse Transcriptase InhibitorsAnti-HIV AgentsReverse Transcriptase InhibitorsAntiretroviral therapyHIV infectionImmune activationInflammation

Identifiers

PMID28434169
PMCPMC5514315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.